Travel Health Evidence

Prevenzjoni

Diarrea tal-vjaġġaturi: x'jipprevjeniha

Il-profilassi taħdem inqas tajjeb milli jimplika l-prodotti, u li tkun taf x'għandek tagħmel meta jiġri huwa aktar importanti minn li tipprevjeniha.

Aġġornat 2 min read 29 ċitazzjonijiet Saħħa tal-evidenza 4/5

Intern ta' ajruplan ta' korp strett b'kaxxi ta' fuq u siġġijiet tlieta f'kull linja
Aykleinman (talk) · Public domain · Wikimedia Commons

X'jagħmel il-profilassi

Meta-analiżi ta' profilassi probiotika [1][3][4] u ta' probiotika mqabbla ma' rifaximin [2] jiskopru tnaqqis modesti fl-inċidenza. Modest huwa l-kelma operattiva: dawn huma tnaqqis tar-riskju relattiv f'kundizzjoni komuni, mhux protezzjoni.

Il-profilassi antibijotika ġeneralment mhix rakkomandata għall-ivvjaġġaturi ordinarji. Tħeġġeġ ir-reżistenza, ġġib effetti sekondarji, u tippromwovi l-kolonizzazzjoni ma' organiżmi reżistenti li l-ivvjaġġaturi mbagħad iġibu d-dar — piż ta' livell popolazzjoni li jitħallas għal konvenjenza ta' livell individwali.

Profilassi għall-diarrea tal-ivvjaġġaturi

Prekawzjonijiet tal-ikel u l-ilma

"Boil it, cook it, peel it or forget it" huwa memorabbli u biss parzjalment effettiv — studji ta' aderenza juru li l-ivvjaġġaturi li jsegwu r-regoli b'attenzjoni xorta jsiru morda f'ratijiet apprezzabbli, prinċipalment minħabba li l-espożizzjoni seħħ f'kċejjen li ma jistgħux jobservaw.

Il-miżuri li għandhom l-aħjar ritorn: ilma fl-iskart jew trattat inkluż għall-teeth, evitazzjoni ta' ġelat ta' provenjenza mhux magħrufa, ikel sħun servut sħun minflok imżewweġ, u frott li tipelek int stess. Il-ħġieġ tal-idejn qabel tiekol jagħmel aktar minn ħafna evitazzjoni tal-ikel.

Meta m'hijiex biss diarreja tal-ivvjaġġaturi

  • Demm fil-ħalib jew febri għoli. Fittex kura medika minflok ittratta lilek innifsek.
  • Sintomi li jdumu aktar minn ġimgħa. Ikkunsidra kawżi parassitiċi, li jeħtieġu trattament differenti.
  • Deidratazzjoni severa, partikolarment f'wlied u ivvjaġġaturi akbar.
  • Sintomi li jibdew wara li terġa' lura. Għid lill-kliniku fejn kont; dan ibiddel id-differenzjali.
  • Sintomi persistenti wara episodju akutu. IBS post-infettiv huwa riżultat rikonoxxut u taħt id-dijanjosi.

Dak il-punt finali jistħoqqlu attenzjoni: minoranza sinifikanti tiżviluppa sintomi tal-istonku li jdumu wara episodju infettiv. Jekk il-ġilda tiegħek qatt ma reġgħet lura għall-normali wara vjaġġ, dak huwa fenomenu rikonoxxut u mhux xi ħaġa li inventajt — ara s-sit tagħna gut-brain evidence site.

Mistoqsijiet komuni

Għandi nieħu probijotiċi qabel nivvjaġġa?
Il-metanaliżi jsibu tnaqqis modest [1][2]. Riskju baxx, kost baxx, aspettattivi baxxi.
Għandi nieħu antibijotiċi profilattikament?
Ġeneralment le. Ir-reżistenza u l-effetti sekondarji jegħlbu l-benefiċċju għal vjaġġar ordinarju.
Il-loperamide huwa sikur biex jintuża?
Għall-kontroll tas-sintomi f'mard mhux sever, iva. Evitah bid-deni jew id-demm fl-ippurgar.
Kemm għandu jdum?
Ħafna każijiet jissolvew fi żmien ftit jiem. Lil hinn minn ġimgħa, mur għal valutazzjoni.
Sinjal tal-farmakija tal-metall proġettat imwaħħal fuq ħajt ta' bini f'Konstanz
L-A rossa gotika hija l-marka standard tal-farmakija f'pajjiżi li jitkellmu bil-Ġermaniż. JoachimKohler-HB · CC BY-SA 4.0 · Wikimedia Commons

Qari relatat

Il-provi li hemm wara din il-paġna Bar imqiegħed li juri l-kompożizzjoni tal-16 pubblikazzjoni msemmija f'din il-paġna skont it-tip ta' studju. 1323meta-analysis (13)review (2)other (3)
16 pubblikazzjonijiet, 2006–2025. Dan huwa bażi b'mod osservazzjonali. Huwa jista' jistabbilixxi li affarijiet iseħħu flimkien; ma jistax jiddetermina liema waħda tikkawża l-oħra. Sors: il-lista ta' ċitazzjonijiet ta' din il-paġna, hawn taħt.

Referenzi

Kull ċitazzjoni hawn taħt tgħaqqad mal-record oriġinali peer-reviewed fuq PubMed jew permezz ta' DOI. Xejn hawnhekk m'għandux ikun sostitut għal parir mediku.

  1. Selected laboratory-based biomarkers for assessing vitamin A deficiency in at-risk individuals Gannon BM, Huey SL, Mehta NH, et al. · The Cochrane database of systematic reviews · 2025 · Meta-analysis DOIPubMed 40433851Full text
  2. Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis Raffetin A, Henningsson AJ, Ornstein K, et al. · Infection · 2025 · Meta-analysis DOIPubMed 40246800
  3. Non-pharmacological interventions designed to support carriers of multi-drug-resistant organisms (MDROs): a systematic literature review Gaube S, Pan M, Rath A, et al. · The Journal of hospital infection · 2025 · Systematic review DOIPubMed 40816599
  4. Investigating the influence of probiotics in preventing Traveler's diarrhea: Meta-analysis based systematic review Alharbi BF, Alateek AA · Travel medicine and infectious disease · 2024 · Meta-analysis DOIPubMed 38458507
  5. Orally Ingested Probiotic, Prebiotic, and Synbiotic Interventions as Countermeasures for Gastrointestinal Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis Fagnant HS, Isidean SD, Wilson L, et al. · Advances in nutrition (Bethesda, Md.) · 2023 · Meta-analysis DOIPubMed 36822240Full text
  6. Probiotics and rifaximin for the prevention of travelers' diarrhea: A systematic review and network meta-analysis Fan H, Gao L, Yin Z, et al. · Medicine · 2022 · Meta-analysis DOIPubMed 36221413Full text
  7. Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea Brum JM, Gibb RD, Ramsey DL, et al. · Digestive diseases and sciences · 2021 · Meta-analysis DOIPubMed 32772204Full text
  8. The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations Abraham A, Bustos JA, Carabin H, et al. · PLoS neglected tropical diseases · 2021 · Meta-analysis DOIPubMed 33788843Full text
  9. Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact Mouchtouri VA, Christoforidou EP, An der Heiden M, et al. · International journal of environmental research and public health · 2019 · Systematic review DOIPubMed 31766548Full text
  10. Prophylactic efficacy of probiotics on travelers' diarrhea: an adaptive meta-analysis of randomized controlled trials Bae JM · Epidemiology and health · 2018 · Meta-analysis DOIPubMed 30189723Full text
  11. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections Domingues AR, Pires SM, Halasa T, et al. · Epidemiology and infection · 2012 · Meta-analysis DOIPubMed 22214729
  12. Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials Hu Y, Ren J, Zhan M, et al. · Journal of travel medicine · 2012 · Meta-analysis DOIPubMed 23379704
  13. Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis Alajbegovic S, Sanders JW, Atherly DE, et al. · Systematic reviews · 2012 · Meta-analysis DOIPubMed 22929178Full text
  14. A meta-analysis of probiotic efficacy for gastrointestinal diseases Ritchie ML, Romanuk TN · PloS one · 2012 · Meta-analysis DOIPubMed 22529959Full text
  15. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients McFarland LV · World journal of gastroenterology · 2010 · Meta-analysis DOIPubMed 20458757Full text
  16. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis Riddle MS, Arnold S, Tribble DR · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2008 · Meta-analysis DOIPubMed 18781873
  17. Meta-analysis of probiotics for the prevention of traveler's diarrhea McFarland LV · Travel medicine and infectious disease · 2007 · Meta-analysis DOIPubMed 17298915
  18. Probiotics in the prevention of traveler's diarrhea: meta-analysis Takahashi O, Noguchi Y, Omata F, et al. · Journal of clinical gastroenterology · 2007 · Meta-analysis DOIPubMed 17426480
  19. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review Riddle MS, Sanders JW, Putnam SD, et al. · The American journal of tropical medicine and hygiene · 2006 · Meta-analysis PubMed 16687698
  20. Scope and applicability of social-ecological resilience to antimicrobial resistance Wernli D, Søgaard Jørgensen P, Parmley EJ, et al. · The Lancet. Planetary health · 2023 · Review DOIPubMed 37438004
  21. Safe Living Following Solid Organ Transplantation Blair BM · The Surgical clinics of North America · 2019 · Review DOIPubMed 30471739
  22. Travel Medicine Leung DT, LaRocque RC, Ryan ET · Annals of internal medicine · 2018 · Review DOIPubMed 29297035
  23. Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 The Lancet. Infectious diseases · 2026 · Journal article DOIPubMed 41412141
  24. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021 Rautalin I, Volovici V, Stark BA, et al. · JAMA neurology · 2025 · Journal article DOIPubMed 40406922Full text
  25. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092927Full text
  26. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092926Full text
  27. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092928Full text
  28. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet. Neurology · 2024 · Journal article DOIPubMed 39304265Full text
  29. Foodborne outbreaks, Austria 2007 Much P, Pichler J, Kasper SS, et al. · Wiener klinische Wochenschrift · 2009 · Journal article DOIPubMed 19280130

Din il-paġna ġiet tradotta awtomatikament mill-Ingliż. Il-citazzjonijiet u n-numri mhumiex mibdula. Aqra l-original Ingliż jekk xi ħaġa taqra b'mod stramb. Aqra l-original Ingliż